Basit öğe kaydını göster

dc.contributor.authorUsta, Mirac Baris
dc.contributor.authorGumus, Yusuf Yasin
dc.contributor.authorAral, Armagan
dc.contributor.authorSay, Gokce Nur
dc.contributor.authorKarabekiroglu, Koray
dc.date.accessioned2020-06-21T13:11:30Z
dc.date.available2020-06-21T13:11:30Z
dc.date.issued2018
dc.identifier.issn1018-8681
dc.identifier.issn1309-5749
dc.identifier.urihttps://doi.org/10.5350/DAJPN2018310107
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11710
dc.descriptionUsta, Mirac Baris/0000-0002-1573-3165en_US
dc.descriptionWOS: 000434284700008en_US
dc.description.abstractObjective: In the literature, children and families have been reported to show high rates of non-adherence to psychopharmacological treatment. This study aimed to investigate psychotropic drug selection, repeat prescription rates, and drug compliance in children who presented to the psychiatry department of a university hospital. Method: Patients examined at the Ondokuz Mayis University Child Psychiatry Outpatient Clinic were included in the study. Patients were retrospectively screened with the Nucleus((R)) system. Results: 12607 patients were included the study, 8889 of whom (70.4%) had received at least one prescription during the follow-up. The mean age of the patients was 12.1 +/- 5.0 years and the male sex ratio was 57.4%. The highest-prescribed drug groups were antipsychotics (32.7%) and stimulants (32.5%). A total of 38432 psychotropic drug prescriptions were made. Patients using psychotropic drugs were given prescriptions 4.32 times on average during this time period, while 2356 patients (26.2%) received one prescription. Conclusions: Over the time period of the study, one out of every four patients who used psychotropic medication only received one prescription. Many of the psychotropic drugs used in children and adolescents are part of long-term treatments, and we observed a high rate of non-adherence to psychopharmacological treatment in children and families. For future research, we recommend to include factors affecting treatment adherence in children and families.en_US
dc.language.isoengen_US
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A Sen_US
dc.relation.isversionof10.5350/DAJPN2018310107en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdolescenten_US
dc.subjectchilden_US
dc.subjectoutpatient treatmenten_US
dc.subjectpsychotropic medicationen_US
dc.titlePsychotropic Medication Use in Children and Adolescents: Review of Outpatient Treatmentsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume31en_US
dc.identifier.issue1en_US
dc.identifier.startpage72en_US
dc.identifier.endpage78en_US
dc.relation.journalDusunen Adam-Journal of Psychiatry and Neurological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster